Document is current
Any future updates will be listed below
-
Authors
Ramdhani, Khalil
van Rees, Rosalie C. M.
Andel, Daan
Roodhart, Jeanine M. L.
Braat, Arthur J. A. T.
Bruijnen, Rutger C. G.
Borel Rinkes, Inne H. M.
Kranenburg, Onno
Lam, Marnix G. E. H.
Smits, Maarten L. J.
Hagendoorn, Jeroen
-
Funding
Funding for this research was provided by:
Stichting Vrienden
Terumo
- License Information
-
More Information
Article History
Received: 12 January 2026
Accepted: 28 April 2026
First Online: 20 May 2026
Declarations
:
: KR has acted as consultant for Eisai and Philips. RCMVR, DA and RCGB have nothing to disclose. MGEHL has acted as a consultant for Boston Scientific, Terumo, Becton and Dickinson, Oncosil, NRG Pallas and Novartis, and receives research support from Novartis, Boston Scientific and Terumo. AJATB acts as consultant for Boston Scientific, Terumo, GEHealthcare, Telix Pharmaceuticals; receives research support from Boston Scientific, Terumo, GE Healthcare, Ariceum Therapeutics, Telix Pharmaceuticals and Siemens. MLJS has acted as consultant for Terumo, Medtronic and Philips. The UMC Utrecht has received research support and royalties from Terumo and Quiremspheres.
: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. Need for informed consent was waived by the institutional medical ethics committee for this retrospective cohort study.
